CellCarta
Todd Chermak serves as the Senior Vice President and Global Business Head for Immunology and Proteomics at CellCarta since August 2020. Previously, Todd held various leadership roles at Abbott from May 1994 to July 2020, including Divisional Vice President for Regulatory Affairs in Rapid Diagnostics and Toxicology, Quality Assurance, Innovation and Development, Abbott Nutrition, CMC and Business Planning, and CMC for Small Molecules and Biologics. Todd's early career included clinical pharmacy work at the University of Chicago Hospitals. Academically, Todd earned a PhD in Pharmacy from the University of Illinois Chicago, a Master's in Engineering and Management Sciences from Northwestern University, and a BS in Pharmacy from Purdue University.
This person is not in any offices
CellCarta
CellCarta's Mission is centered on collaborating and partnering with pharmaceutical and biotech companies through proteomics and immune monitoring enabling the acceleration of precision medicine in drug development.With a vision and deep understanding of the needs for complex immune monitoring in novel drug development, Caprion integratedImmuneCarta (formerly known as National Immune Monitoring), with its established and proven proteomics service, ProteoCarta. Together, Caprion now offers a fully integrated and unique service offering to its partners.